Diagnostic and therapeutic value of intracellular biomarker testing in chronic pain.
Pain Manag
; 14(1): 21-27, 2024 Jan.
Article
en En
| MEDLINE
| ID: mdl-38193288
ABSTRACT
Aim:
Micronutrient and metabolic compound supplementation as a method of treating chronic pain is not well understood. Case A 58 year-old woman presented with refractory painful neuropathy. She did not respond to conservative treatment and was seeking spinal cord stimulator implantation. She underwent a biomarker panel that revealed low intracellular levels of multiple compounds. As she supplemented her deficiencies, her symptoms fully resolved, and the implant was no longer indicated.Discussion:
Micronutrient and metabolic compound testing could potentially expand non-invasive treatment options for patients with refractory chronic pain. Caution should be exercised given limited regulatory oversight in the supplement industry and actively ongoing nutritional research.Conclusion:
Biomarker testing panels may be a useful adjunct in the management of refractory neuropathic pain.Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Dolor Intratable
/
Terapia por Estimulación Eléctrica
/
Dolor Crónico
/
Neuralgia
Tipo de estudio:
Diagnostic_studies
Límite:
Female
/
Humans
/
Middle aged
Idioma:
En
Revista:
Pain Manag
Año:
2024
Tipo del documento:
Article
País de afiliación:
Estados Unidos